News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Harvard Bioscience Inc. (HBIO) Announces Allocation Of Tax Basis for Spin-Off Of Harvard Apparatus (HART) Regenerative Technology


11/13/2013 10:15:27 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

HOLLISTON, Mass., Nov. 13, 2013 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer, and marketer of a broad range of tools to advance life science research, announced the allocation of tax basis resulting from the tax-free spin-off of Harvard Apparatus Regenerative Technology, Inc. Based on the relative fair market values of the respective companies on November 1, 2013, the first day of trading after distribution, 23.63 percent of a stockholder`s pre-distribution tax basis in Harvard Bioscience common stock should be allocated to the shares of common stock in Harvard Apparatus Regenerative Technology received pursuant to the distribution described in the Information Statement of Harvard Apparatus Regenerative Technology dated October 17, 2013.

Help employers find you! Check out all the jobs and post your resume.

Read at GlobeNewswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES